HomeBusinessReal Estate & Housing Market NewsKROS, ASND, GOSS: Biopharma Stocks To Watch In 2024

KROS, ASND, GOSS: Biopharma Stocks To Watch In 2024

Keros Therapeutics (KROS) is a clinical-stage biopharmaceutical company that develops therapies for hematologic and cardiovascular disease. Wedbush’s Andreas Argyrides breaks down the biopharma space, as Wedbush has an outperform rating and an $86 price target on KROS. He also talks about Asecndis Pharma (ASND) which is on Wedbush’s top picks for 2024. He then goes over Gossamer Bio (GOSS) which is developing Seralutinib (GB002) for the treatment of PAH. Tune in to find out more about the stock market today.

Market On Close

21 Dec 2023

SHARE

ON AIR
9:30 pm
Next Gen Investing
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
ON AIR
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now